Preferred Label : Bevacizumab/Temozolomide Regimen;
NCIt synonyms : Avastin/Temodar; Bevacizumab-Temozolomide; Bevacizumab/Temozolomide;
NCIt related terms : Temozolomide and Bevacizumab; Temozolomide and Bevacizumab-maly; Temozolomide and Bevacizumab-onbe; Temozolomide and Bevacizumab-bvzr; Temozolomide and Bevacizumab-awwb; Temozolomide and Bevacizumab-aybi; Temozolomide and Bevacizumab-adcd; Temozolomide and Bevacizumab-equi;
NCIt definition : A regimen consisting of bevacizumab and temozolomide that may be used in the treatment
of central nervous system (CNS) cancers, including astrocytoma, oligodendroglioma
and glioblastoma, and solitary fibrous tumors (SFTs).;
NCI Metathesaurus CUI : CL969521;
Codes from synonyms : 25802; 127638; 127564; 127268; 127416; 127490; 127194; 127342;
Origin ID : C160528;
UMLS CUI : C5205332;
Semantic type(s)
chemotherapy_regimen_has_component
concept_is_in_subset